NaturoMed Therapeutics, the parent company of Stay Wyld Organics, is a vertically integrated functional and medicinal mushroom company. NaturoMed Therapeutics is currently producing bulk functional mushroom powders at its state of the art facility in BC, Canada and selling functional mushroom products to the retail market throughout North America. The company is committed to improving global mental and physical health through the production and distribution of high-quality Canadian grown organic mushroom products. NaturoMed is excited to announce that construction is well underway for its Health Canada Controlled Substances Dealer’s License to produce Psilocybin. Estimated completion is Q4, 2022. NaturoMed plans to produce Psilocybin once it receives the license. NaturoMed’s lead scientist is currently working on new extraction processes to create medicinal IP.
Similar Posts
MAPS Founder Rick Doblin Discusses MDMA Research for PTSD With Actress Mayim Bialik
Rick Doblin, the founder of MAPS, joined actress Mayim Bialik’s podcast Breakdown to discuss MDMA and PTSD research.
If Your Psychedelic Experience Isn’t Going According to Plan, Call a Psychedelic Helpline
A recent study published in the National Library of Medicine found that a psychedelic helpline is an effective tool in minimizing harms and promoting safe nonclinical psychedelic use.
From Dynamic Entrepreneur to an Advocate Psychedelic Medicine: Tim Ferris
When discussing notable figures that are influencing the emerging psychedelic…
How Magic Mushrooms Affect the 5 Senses
While magic mushrooms don’t alter your senses directly, they modify how your brain processes external stimuli, heightening sensations or producing deep emotional reactions.
Brain Scanning Technology to be Used for Psychedelic Clinical Trials in Pioneering London Start-Up Partnership
A start-up partnership between Clerkenwell Health and MYndspan will use brain scanning technology for psychedelic clinical trials.
Psychedelic Decriminalization is on the Ballot in Colorado
This November, Colorado voters have the chance to decriminalize psychedelic plant medicines for personal and therapeutic use